Dr Moira Cruickshank
Research Fellow
- About
-
- Email Address
- m.cruickshank@abdn.ac.uk
- Office Address
Health Services Research Unit
3rd Floor Health Sciences Building
Foresterhill
Aberdeen
AB25 2ZD- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
I joined the Knowledge Synthesis team of ACE following completion of my PhD in 2011. I have worked on a wide range of technology assessment appraisals and health technology assessment reviews.
Qualifications
- PhD Health Psychology2011 - University of Aberdeen
- Publications
-
Page 1 of 3 Results 1 to 25 of 56
Acalabrutinib with bendamustine and rituximab for untreated mantle cell lymphoma [ID6155]
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned ReportsExperiences of women from ethnic minorities and underserved, marginalised and disadvantaged groups in communicating with health professionals during antenatal care: An overview of qualitative systematic reviews
NIHR Open Research, vol. 6, 2Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/nihropenres.14096.1
Duration of wound coverage for the prevention of surgical site infections after surgery: A systematic review of current evidence with meta-analysis of randomised controlled trials
International Wound Journal, vol. 23, no. 5, e70943Contributions to Journals: ArticlesWhat are the information and decision-support needs of women planning mode of birth in routine antenatal care in high-income countries? A qualitative evidence synthesis
NIHR Open Research, vol. 6, 4Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/nihropenres.14178.1
Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation
Health Technology Assessment, vol. 30, no. 8Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/QLAS8524
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/2a9e67be-cb4d-4add-ba67-588402f2e050/download
Trifluridine-tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatments [ID6298]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned ReportsWhat are the influences on women’s preferences and decision-making when planning mode of birth in high-income countries? A qualitative systematic review
AJOG Global Reports, vol. 5, no. 3, 100556Contributions to Journals: ArticlesThe regenerate study: A non-randomised feasibility study of an intervention to reduce anticholinergic burden in older patients
Geriatrics, vol. 9, no. 6, 152Contributions to Journals: ArticlesAlternatives to surveillance for persistent human papillomavirus after a positive cervical screen:: A systematic review and meta-analysis
European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 302, pp. 332-338Contributions to Journals: ArticlesAutomated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis
Health Technology Assessment, vol. 28, no. 37, pp. i-xxv, 1-158Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/TWCG3912
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/8339062f-df2a-43e0-824c-181c1da4773c/download
The effects and safety of testosterone replacement therapy for men with hypogonadism: The TestES evidence synthesis and economic evaluation
Health Technology Assessment, vol. 28, no. 43Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3310/JRYT3981
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/6848212e-6da3-4654-8ab5-bdb67252f855/download
- [ONLINE] View publication in Scopus
Fruquintinib for previously treated metastatic colorectal cancer [ID6274]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned ReportsWhat is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence
PloS ONE, vol. 19, no. 3 , e0299743Contributions to Journals: Review articlesCost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels
Andrology, vol. 12, no. 3, pp. 477-486Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/andr.13597
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/4998c88d-7fcf-4594-b082-8eb2eb688d19/download
- [ONLINE] View publication in Scopus
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
National Institute for Health and Care Excellence (NICE). 20 pagesBooks and Reports: Commissioned Reports- [ONLINE] https://www.nice.org.uk/guidance/ta948
- [ONLINE] Page 214-316
- [ONLINE] https://www.nice.org.uk/guidance/ta948/evidence
Netarsudil-latanoprost for previously treated openangle glaucoma or ocular hypertension [ID1363]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned ReportsClinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo:: Results Of Individual Patient And Aggregate Data Meta-analyses
Annual Meeting of the Endocrine Society 2023, bvad114.1704Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvad114.1704
Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 4, no. 10, pp. e561-e572Contributions to Journals: ArticlesDeucravacitinib for treating moderate-to-severe plaque psoriasis
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 155 pagesBooks and Reports: Commissioned ReportsSecukinumab for Moderate-to-Severe Hidradenitis Suppurativa [ID4039]: NICE Single Technology Appraisal
Commissioned by National Institute for Health and Care Excellence (NICE). Aberdeen HTA GroupBooks and Reports: Commissioned ReportsPMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvac150.1447
PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
Annual Meeting of the Endocrine Society 2022Contributions to Conferences: Posters- [ONLINE] DOI: https://doi.org/10.1210/jendso/bvac150.1445
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence
Journal of Neurology, vol. 269, no. 7, pp. 3420-3429Contributions to Journals: Review articles- [ONLINE] DOI: https://doi.org/10.1007/s00415-022-10979-2
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/37bb6e56-6464-46d4-9661-f1cacc32dc10/download
- [ONLINE] View publication in Scopus
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after one systemic therapy
London: Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence. 128 pagesBooks and Reports: Commissioned ReportsAdverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
The Lancet Healthy Longevity, vol. 3, no. 6, pp. e381–393Contributions to Journals: Articles